Queenborough & Rushenden – Twyford Demolition and Enabling Works

Queenborough and Rushenden is a major development site within the HCA’s Economic Assets Programme and a key component of the Kent and Medway Stewardship Plan. The HCA have also acquired the Klondyke site, and together with the Twyfords site represents a total of 20 hectares to be brought forward for mixed-use regeneration. In conjunction with the Caradon site to the south, these sites will provide 2,000 new homes and circa 180,000m2 of employment space on the Isle of Sheppey in North Kent.

Tenders are being sought from specialist Contractors to undertake the following works on the Twyford site:

Core Works

Additional Works

Additional information: The closing time for tenders is 1pm.

The Invitation to Tender, Tender Return Label and Pricing Schedule can be downloaded from this notice. All other supporting documentation can be found at https://upload.hca-online.org.uk/tenders/hcap16068/hcap16068.zip

All discussions, meetings and communications will be conducted in English.

The contract will be subject to English law. Tenders and all supporting documents must be priced in GBP and all payments under the contract will be made in GBP.

Contractors must be licensed by the HSE and also be members of the Asbestos Removal Contractors Association (ARCA). In addition to ARCA we also recognise ACAD (Asbestos Control & Abatement Division).

This procurement and award is subject to the transparency arrangements being adopted by the UK Government. These arrangements include the publication of tender documentation issued by the HCA and the contract between the HCA and supplier. Bidders should highlight any areas they consider commercially sensitive in order for the HCA to be able to honour our transparency obligations without undermining the bidders commercial interests.

Candidates are advised that the HCA is subject to the Freedom of Information Act 2000 ("The Act"). If a candidate considers that any of the information supplied as part of this procurement procedure should not be disclosed because of its commercial sensitivity, confidential or otherwise, they must, when providing this information, clearly identify the specific information they do not wish to be disclosed and clearly specify the reasons for its sensitivity. The HCA shall take such statements into consideration in the event that it receives a request pursuant to the Act which relates to the information provided by the interested party. Please note, it is insufficient to include a statement of confidentiality encompassing all the information provided in the response.

The HCA takes a zero-tolerance approach to bribery and corruption and sets high standards of impartiality, integrity and objectivity in relation to the stewardship of public funds and the management of its activities. The principles contained within this policy apply to both internal and external audiences, including anyone wishing to undertake business or engage with the HCA. Please refer to our Anti-bribery and Corruption Policy by visiting https://www.gov.uk/government/publications/anti-bribery-and-corruption-policy for further information.